148 related articles for article (PubMed ID: 7523870)
21. Identification of core structure and critical T cell receptor contact residues in an antigenic peptide by measuring acidification rates.
Arimilli S; Deshpande SV; Nag B
J Immunol Methods; 1998 Mar; 212(1):49-59. PubMed ID: 9671152
[TBL] [Abstract][Full Text] [Related]
22. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
23. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
Moisini I; Nguyen P; Fugger L; Geiger TL
J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
[TBL] [Abstract][Full Text] [Related]
24. N-linked oligosaccharides of murine major histocompatibility complex class II molecule. Role in antigenic peptide binding, T cell recognition, and clonal nonresponsiveness.
Nag B; Passmore D; Kendrick T; Bhayani H; Sharma SD
J Biol Chem; 1992 Nov; 267(31):22624-9. PubMed ID: 1385402
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of T cells by antigenic peptide complexed with isolated chains of major histocompatibility complex class II molecules.
Nag B; Wada HG; Deshpande SV; Passmore D; Kendrick T; Sharma SD; Clark BR; McConnell HM
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1604-8. PubMed ID: 7679510
[TBL] [Abstract][Full Text] [Related]
26. Anergy induction by dimeric TCR ligands.
Appel H; Seth NP; Gauthier L; Wucherpfennig KW
J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
[TBL] [Abstract][Full Text] [Related]
27. T-cell receptor-mediated signal transduction in transformed human T-cells.
Arimilli S; Nag B
Recept Signal Transduct; 1997; 7(3):151-63. PubMed ID: 9440502
[TBL] [Abstract][Full Text] [Related]
28. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.
Li Y; Huang Y; Lue J; Quandt JA; Martin R; Mariuzza RA
EMBO J; 2005 Sep; 24(17):2968-79. PubMed ID: 16079912
[TBL] [Abstract][Full Text] [Related]
29. The role of N-linked oligosaccharides of MHC class II antigens in T cell stimulation.
Nag B; Wada HG; Arimilli S; Fok K; Passmore D; Sharma SD; McConnell HM
J Immunol Methods; 1994 Jun; 172(1):95-104. PubMed ID: 7515935
[TBL] [Abstract][Full Text] [Related]
30. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
31. Intramolecular charge heterogeneity in purified major histocompatibility class II alpha and beta polypeptide chains.
Nag B; Arimilli S; Koukis B; Rhodes E; Baichwal V; Sharma SD
J Biol Chem; 1994 Apr; 269(13):10061-70. PubMed ID: 8144505
[TBL] [Abstract][Full Text] [Related]
32. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.
Wucherpfennig KW; Catz I; Hausmann S; Strominger JL; Steinman L; Warren KG
J Clin Invest; 1997 Sep; 100(5):1114-22. PubMed ID: 9276728
[TBL] [Abstract][Full Text] [Related]
33. MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR V beta CDR2 peptides: comparison with myelin basic protein-specific T cells.
Chou YK; Weinberg AD; Buenafe A; Bourdette DN; Whitham R; Kaleeba JA; Robey IF; Kavanagh DG; Offner H; Vandenbark AA
J Neurosci Res; 1996 Sep; 45(6):838-51. PubMed ID: 8892096
[TBL] [Abstract][Full Text] [Related]
34. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells.
Nag B; Kendrick T; Arimilli S; Yu SC; Sriram S
Cell Immunol; 1996 May; 170(1):25-33. PubMed ID: 8660796
[TBL] [Abstract][Full Text] [Related]
35. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation.
Wang C; Mooney JL; Meza-Romero R; Chou YK; Huan J; Vandenbark AA; Offner H; Burrows GG
J Immunol; 2003 Aug; 171(4):1934-40. PubMed ID: 12902496
[TBL] [Abstract][Full Text] [Related]
36. Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses.
Fridkis-Hareli M; Stern JN; Fugger L; Strominger JL
Hum Immunol; 2001 Aug; 62(8):753-63. PubMed ID: 11476898
[TBL] [Abstract][Full Text] [Related]
37. Recombinant adenovirus coexpressing covalent peptide/MHC class II complex and B7-1: in vitro and in vivo activation of myelin basic protein-specific T cells.
Chen J; Huber BT; Grand RJ; Li W
J Immunol; 2001 Aug; 167(3):1297-305. PubMed ID: 11466346
[TBL] [Abstract][Full Text] [Related]
38. Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft.
Lee C; Liang MN; Tate KM; Rabinowitz JD; Beeson C; Jones PP; McConnell HM
J Exp Med; 1998 May; 187(9):1505-16. PubMed ID: 9565642
[TBL] [Abstract][Full Text] [Related]
39. Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.
Fridkis-Hareli M; Santambrogio L; Stern JN; Fugger L; Brosnan C; Strominger JL
J Clin Invest; 2002 Jun; 109(12):1635-43. PubMed ID: 12070311
[TBL] [Abstract][Full Text] [Related]
40. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis.
Zang YC; Kozovska M; Aebischer I; Li S; Boehme S; Crowe P; Rivera VM; Zhang JZ
Int Immunol; 1998 Jul; 10(7):991-8. PubMed ID: 9701037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
